Discover 194 paid clinical trials in Vermont. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Vermont offers a variety of opportunities for both healthy volunteers interested in taking part in paid studies and those with specific health conditions. Research centers in Burlington, Rutland, and Montpelier are actively recruiting, granting access to cutting-edge therapies and innovative medical care.
Filter
1
Filter results
Results: 194
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
for
Breast Carcinoma, Colorectal Carcinoma,
Location: Rockport ME, Belfast ME, Brunswick ME, Augusta ME,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06418204
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
for
Parkinsons Disease (PD)
Location: Boston MA, Providence RI, New York NY, Burlington VT,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 45 - 70+
Code: NCT06944522
Phase 3, Recruiting
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
for
Cigarette Smoking-Related Carcinoma
Location: Saint Johnsbury VT, Lebanon NH, New York NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05008848
Phase 3, Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
for
Metastatic Colorectal Adenocarcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Greenlawn NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05673148
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Bar Harbor ME, Boston MA, Concord NH, New York NY,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase 2, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Brewer ME, South Weymouth MA, Boston MA, Brighton MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 70+
Code: NCT06096844
Phase 3, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06661720
Phase 3, Recruiting
Quetiapine for the Treatment of Insomnia in Alzheimer's Disease
for
Alzheimer's Disease, Insomnia
Location: Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 55 - 70+
Code: NCT00232570
Recruiting
Behavioral Weight Loss and Exercise After Treatment (BEAT)
for
Breast Cancer
Location: Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 21 - 69
Code: NCT02052115
Recruiting
Vermont Oxford Network Very Low Birth Weight Database
for
Neonatology
Location: Burlington VT
Sponsor: Vermont Oxford Network
Sex: All
Age: 0
Code: NCT01825499
Recruiting
Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women
for
Stage I Breast Cancer
Location: Burlington VT
Sponsor: University of Vermont
Sex: Female
Age: 65+
Code: NCT00337064
Phase 1, Phase 2, Recruiting
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Boston MA, Quebec, Fairfield CT, Lake Success NY,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06290141
Phase 3, Recruiting
Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer